Checkpoint Therapeutics Inc (CKPT) — Financial Flexibility Index
Checkpoint Therapeutics Inc (CKPT) has a Financial Flexibility Index of -0.65x as of March 2025. Free cash flow of $-11.69 Million (operating CF $-11.69 Million minus capex $0.00) represents -1% of total liabilities ($17.87 Million). Check Checkpoint Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Checkpoint Therapeutics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Checkpoint Therapeutics Inc across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Checkpoint Therapeutics Inc generate cash.
Annual Financial Flexibility Index for Checkpoint Therapeutics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Checkpoint Therapeutics Inc. Explore CKPT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.55x | $-31.10 Million | $-31.10 Million | $20.10 Million | ▲ +40.1% |
| 2023 | -2.58x | $-47.59 Million | $-47.59 Million | $18.43 Million | ▼ -47.1% |
| 2022 | -1.76x | $-57.55 Million | $-57.55 Million | $32.77 Million | ▼ -73.5% |
| 2021 | -1.01x | $-26.31 Million | $-26.31 Million | $25.98 Million | ▲ +55.9% |
| 2020 | -2.29x | $-16.55 Million | $-16.55 Million | $7.22 Million | ▲ +12.9% |
| 2019 | -2.63x | $-21.37 Million | $-21.37 Million | $8.12 Million | ▼ -33.6% |
| 2018 | -1.97x | $-25.80 Million | $-25.80 Million | $13.09 Million | ▲ +16.6% |
| 2017 | -2.36x | $-15.06 Million | $-15.46 Million | $6.37 Million | ▼ -27.9% |
| 2016 | -1.85x | $-6.79 Million | $-9.95 Million | $3.67 Million | ▼ -655.5% |
| 2015 | 0.33x | $1.42 Million | $-1.11 Million | $4.26 Million | — |